Login / Signup

Efficacy and safety of commonly used thromboprophylaxis agents following hip and knee arthroplasty.

Tim CheokAlexander BeveridgeMorgan BermanMartin CoiaAlexander CampbellTycus T S TseJob N DoornbergRuurd L Jaarsma
Published in: The bone & joint journal (2024)
We recommend the use of either aspirin < 325 mg daily, enoxaparin, or dabigatran for VTE prophylaxis following hip and knee arthroplasty.
Keyphrases
  • venous thromboembolism
  • direct oral anticoagulants
  • total hip arthroplasty
  • low dose
  • atrial fibrillation
  • physical activity
  • cardiovascular events
  • type diabetes